Shortage Watch Free FDA drug-shortage watch

← all medications

Cobicistat Tablet

Brand names: Tybost

Category: Antiviral

Not specified 1

FDA status: To Be Discontinued · Last FDA update: Oct 7, 2025 · First posted: Oct 7, 2025 · 1 manufacturers, 1 listed presentations

As of Oct 7, 2025, the FDA lists Cobicistat Tablet as being discontinued. Of 1 manufacturer presentations, 1 Not specified.

Ask your pharmacist: which of the 1 manufacturers below can they order right now, and whether a different strength or form of Cobicistat Tablet is available. For alternatives, talk to your prescriber — see what to do if your medication is in shortage.
Presentation & package NDCManufacturerAvailabilityFDA note
Tybost, Tablet, 150 mg (NDC 61958-1401-1)
NDC 61958-1401-1		 Gilead Sciences, Inc. Not specified Gilead plans to sell through the end of February 2026. Discontinuation of the manufacture of the drug due to business reasons.

Related medications in shortage

Other Antiviral medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.

Change log

No changes recorded yet.
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.

Cite this: “FDA drug-shortage status for Cobicistat Tablet (FDA data as of Oct 7, 2025). Shortage Watch, openFDA.”

Get an email when this record changes

One email, only when the FDA changes something for Cobicistat Tablet. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.

Check your inbox - click the confirmation link to activate alerts for Cobicistat Tablet.

Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.

Embed a live status badge: /badge/cobicistat-tablet.svg

FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).